BR112023017802A2 - Marcadores de interação cromossômica - Google Patents
Marcadores de interação cromossômicaInfo
- Publication number
- BR112023017802A2 BR112023017802A2 BR112023017802A BR112023017802A BR112023017802A2 BR 112023017802 A2 BR112023017802 A2 BR 112023017802A2 BR 112023017802 A BR112023017802 A BR 112023017802A BR 112023017802 A BR112023017802 A BR 112023017802A BR 112023017802 A2 BR112023017802 A2 BR 112023017802A2
- Authority
- BR
- Brazil
- Prior art keywords
- interaction markers
- chromosome interaction
- markers
- chromosome
- chromosomal
- Prior art date
Links
- 230000003993 interaction Effects 0.000 title abstract 3
- 210000000349 chromosome Anatomy 0.000 title 1
- 230000002759 chromosomal effect Effects 0.000 abstract 2
- 238000002619 cancer immunotherapy Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163156659P | 2021-03-04 | 2021-03-04 | |
| US202163282284P | 2021-11-23 | 2021-11-23 | |
| PCT/GB2022/050561 WO2022185062A1 (en) | 2021-03-04 | 2022-03-03 | Chromosome interaction markers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023017802A2 true BR112023017802A2 (pt) | 2023-12-12 |
Family
ID=80735500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023017802A BR112023017802A2 (pt) | 2021-03-04 | 2022-03-03 | Marcadores de interação cromossômica |
Country Status (15)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202412610D0 (en) * | 2024-08-28 | 2024-10-09 | Oxford BioDynamics PLC | Screening method |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111511930B (zh) * | 2017-11-03 | 2024-11-22 | 牛津生物动力有限责任公司 | 通过染色体相互作用遗传调节免疫响应 |
| WO2020198676A1 (en) * | 2019-03-28 | 2020-10-01 | Bristol-Myers Squibb Company | Methods of treating tumor |
| GB2626699B (en) * | 2019-05-08 | 2024-11-20 | Oxford BioDynamics PLC | Chromosome Conformation Markers of Prostate Cancer and Lymphoma |
| WO2021228888A1 (en) * | 2020-05-12 | 2021-11-18 | Asylia Diagnostics | Biomarkers for hyperprogressive disease and therapy response after immunotherapy |
-
2022
- 2022-03-02 TW TW111107496A patent/TW202302862A/zh unknown
- 2022-03-03 BR BR112023017802A patent/BR112023017802A2/pt unknown
- 2022-03-03 ES ES22709783T patent/ES3029416T3/es active Active
- 2022-03-03 IL IL304883A patent/IL304883A/en unknown
- 2022-03-03 PL PL22709783.9T patent/PL4301874T3/pl unknown
- 2022-03-03 AU AU2022230780A patent/AU2022230780B2/en active Active
- 2022-03-03 JP JP2023553436A patent/JP2024511292A/ja active Pending
- 2022-03-03 KR KR1020237033851A patent/KR20240006020A/ko active Pending
- 2022-03-03 EP EP22709783.9A patent/EP4301874B1/en active Active
- 2022-03-03 US US18/547,579 patent/US20240229135A9/en active Pending
- 2022-03-03 HU HUE22709783A patent/HUE071359T2/hu unknown
- 2022-03-03 WO PCT/GB2022/050561 patent/WO2022185062A1/en not_active Ceased
- 2022-03-03 CA CA3209544A patent/CA3209544A1/en active Pending
- 2022-03-03 GB GB2313067.7A patent/GB2618727B/en active Active
-
2023
- 2023-09-28 ZA ZA2023/09162A patent/ZA202309162B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024511292A (ja) | 2024-03-13 |
| US20240229135A9 (en) | 2024-07-11 |
| TW202302862A (zh) | 2023-01-16 |
| AU2022230780A1 (en) | 2023-10-12 |
| EP4301874C0 (en) | 2025-04-23 |
| HUE071359T2 (hu) | 2025-08-28 |
| ES3029416T3 (en) | 2025-06-24 |
| EP4301874B1 (en) | 2025-04-23 |
| GB202313067D0 (en) | 2023-10-11 |
| WO2022185062A1 (en) | 2022-09-09 |
| AU2022230780B2 (en) | 2024-05-23 |
| ZA202309162B (en) | 2025-03-26 |
| GB2618727A (en) | 2023-11-15 |
| US20240132959A1 (en) | 2024-04-25 |
| PL4301874T3 (pl) | 2025-06-23 |
| GB2618727B (en) | 2024-07-17 |
| KR20240006020A (ko) | 2024-01-12 |
| CA3209544A1 (en) | 2022-09-09 |
| EP4301874A1 (en) | 2024-01-10 |
| IL304883A (en) | 2023-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022014166A (es) | Metodos para tratar el mieloma multiple. | |
| BR112022002604A2 (pt) | Processo de produção de moduladores de cftr | |
| CL2021001690S1 (es) | Estuche para audífonos. | |
| BR112019018124A2 (pt) | composições e métodos para imunooncologia | |
| CL2020001637A1 (es) | Anticuerpos para lilrb2 | |
| MX384823B (es) | Agentes de alta afinidad dirigidos a antígeno de membrana específico de próstata para endoradioterapia de cáncer de próstata. | |
| CL2019001252S1 (es) | Herramienta de corte. | |
| CL2021001175S1 (es) | Estuche para audífonos. | |
| MX420023B (es) | Moléculas guía sintéticas, composiciones y métodos relacionados con éstas. | |
| CO2017010618A2 (es) | Anticuerpos contra icos | |
| CO2018013112A2 (es) | Compuestos de carfilzomib pegilados | |
| UY40769A (es) | “ANTICUERPOS AISLADOS BIESPECÍFICOS GPRC5D x CD3 Y COMPOSICIONES QUÍMICAS QUE LOS CONTIENEN” | |
| EP4162044A4 (en) | GUIDE RNA TEMPLATE MOLECULES | |
| BR112015032718A2 (pt) | composto de modificação de splicing do gene foxm1, uso do composto, formulação farmacêutica e métodos de triagem de compostos | |
| CL2020002510A1 (es) | Radiofármaco dirigido a antígeno de membrana específico de próstata (psma) para diagnosticar y tratar el cáncer de próstata | |
| AU2017261442A1 (en) | Detection of chromosome interaction relevant to breast cancer | |
| BR112021024852A2 (pt) | Métodos de cultura de célula e composições para produção de anticorpo | |
| MX374630B (es) | Metodo para el acabado de engranajes templados. | |
| BR112016026009A2 (pt) | Processo para fazer polímeros à base de etileno, usando iniciadores de hidrocarbonetos | |
| BR112017000417A2 (pt) | processo para preparação de fenil alcanos substituídos | |
| CL2023000942A1 (es) | Síntesis de un inhibidor de calicreína plasmática a escala de proceso . | |
| PT3806992T (pt) | Processo e instalação para a produção de metanol | |
| MY200184A (en) | Biomarker | |
| ZA202309162B (en) | Chromosome interaction markers | |
| MY203765A (en) | Chromosome conformation markers of prostate cancer and lymphoma |